Dapagliflozin associated with higher risk of ketoacidosis in T2DM patients

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1900卷 / 1期

关键词：

D O I：

10.1007/s40278-022-12358-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：6 / 6

相关论文

共 50 条

[41] Effect of Dapagliflozin on Renal Oxygen Delivery and Consumption in T2DM and NGT Subjects
Tripathy, Devjit
Chen, Xi
Chilton, Robert
Hansis-Diarte, Andrea A.
Salehi, Marzieh
Solis-Herrera, Carolina
Cersosimo, Eugenio
Defronzo, Ralph A.
DIABETES, 2023, 72
[42] Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects
Chen, Xi
Solis-Herrera, Carolina
Tripathy, Devjit
Hansis-Diarte, Andrea A.
Chilton, Robert
Cersosimo, Eugenio
Defronzo, Ralph A.
DIABETES, 2022, 71
[43] Dapagliflozin, Metformin-XR, or Both Together as Initial Therapy for T2DM
Henry, Robert R.
Murray, Alexander V.
Marmolejo, Marisol Herrera
Hennicken, Delphine
Ptaszynska, Agata
List, James F.
DIABETES, 2011, 60 : A84 - A84
[44] New marker to predict risk of T2DM
David Holmes
Nature Reviews Endocrinology, 2017, 13 : 625 - 625
[45] Psoriasis might increase risk of T2DM
Nature Reviews Endocrinology, 2012, 8 (9) : 508 - 508
[46] Melatonin signalling implicated in the risk of T2DM
Claire Greenhill
Nature Reviews Endocrinology, 2016, 12 (7) : 374 - 374
[47] Genetic T2DM risk factor found
Linda Koch
Nature Reviews Endocrinology, 2014, 10 (3) : 128 - 128
[48] Dapagliflozine is now available for patients with T2DM (cardiovascular and/or renal risk)
Blond, Brigitte
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2020, 24 (03): : 119 - 119
[49] New marker to predict risk of T2DM
Holmes, David
NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (11) : 625 - 625
[50] Atypical antipsychotics: risk of T2DM in children
Reactions Weekly, 2015, 1548 (1) : 8 - 8

← 1 2 3 4 5 →